Update: 13.03.2023
Last week: 9 week 2023 (27.02.2023 - 05.03.2023)
Last full month: February 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 104 662 | 3.4% | 2.7% | 0 | 27 620 480 | 1.5% | 3.2% | -0.1 | 4.1% |
| MoM | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| YTD | 985 672 | -68.9% | 2.8% | -3.2 | 266 560 080 | -56.2% | 3.4% | -2.3 | -32.9% |
| MAT | 7 667 030 | -48.3% | 4.1% | -2.5 | 1 678 699 970 | -36.1% | 4.1% | -1.9 | -16.8% |
| DEXALGIN | |||||||||
| WoW | 16 012 | 11.3% | 0.3% | 0 | 8 687 074 | 9.2% | 1.1% | 0 | 8.5% |
| MoM | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| YTD | 154 601 | -63.9% | 0.4% | -0.4 | 83 240 709 | -50.7% | 1.3% | -0.9 | -23.9% |
| MAT | 1 311 834 | -32.9% | 0.5% | -0.2 | 601 185 052 | -20.1% | 1.5% | -0.4 | -9.2% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 54 841 | 14.5% | 38.7% | 0 | 34 762 625 | 15.3% | 48.3% | 0 | 14.4% |
| MoM | 202 093 | -11.2% | 38.4% | -1 | 128 123 690 | -13.1% | 48.0% | -2.2 | -8.9% |
| YTD | 461 281 | -57.8% | 38.9% | -22.1 | 295 891 565 | -43.9% | 49.2% | -18 | -33.9% |
| MAT | 3 651 355 | -32.6% | 48.9% | -15.4 | 1 977 081 579 | -22.0% | 55.4% | -14.1 | -11.4% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 290 | 9.8% | 28.4% | -0.6 | 16 483 022 | 9.0% | 44.9% | -1.1 | 12.2% |
| MoM | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| YTD | 182 461 | -42.4% | 29.4% | -10 | 142 490 933 | -23.6% | 46.5% | -7.3 | -22.7% |
| MAT | 1 291 915 | -21.9% | 35.1% | -5.7 | 861 508 850 | -11.3% | 49.0% | -6.4 | -9.2% |
| FASTUM | |||||||||
| WoW | 14 570 | 15.1% | 0.8% | 0 | 8 781 314 | 14.2% | 2.1% | -0.1 | 16.6% |
| MoM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| YTD | 129 783 | -49.9% | 0.9% | -0.6 | 79 272 251 | -35.5% | 2.4% | -0.6 | -18.0% |
| MAT | 911 441 | -33.6% | 1.0% | -0.4 | 502 644 246 | -21.5% | 2.4% | -0.7 | -4.5% |
| IODOMARIN | |||||||||
| WoW | 74 336 | 21.7% | 22.5% | 0.3 | 13 975 308 | 21.5% | 9.3% | 0.4 | 20.2% |
| MoM | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| YTD | 565 930 | -20.2% | 21.7% | -0.1 | 105 547 038 | -21.2% | 8.6% | -1 | -19.9% |
| MAT | 3 150 356 | -6.7% | 20.5% | -0.8 | 611 681 337 | -3.3% | 8.9% | -0.7 | -3.2% |
| LIOTON | |||||||||
| WoW | 15 328 | 6.0% | 1.5% | -0.2 | 19 622 736 | 9.9% | 4.0% | -0.4 | 18.2% |
| MoM | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.7% |
| YTD | 133 983 | -52.2% | 1.7% | -0.9 | 167 570 057 | -34.6% | 4.3% | -0.9 | -25.6% |
| MAT | 1 105 526 | -35.8% | 2.1% | -0.7 | 1 218 796 764 | -16.6% | 4.5% | -1.2 | -12.7% |
| MEZYM | |||||||||
| WoW | 211 238 | 4.4% | 19.0% | -0.9 | 33 536 102 | 5.7% | 12.8% | -0.3 | 9.5% |
| MoM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| YTD | 1 912 562 | -58.6% | 19.4% | -11.3 | 299 644 551 | -56.0% | 13.2% | -9.3 | -34.5% |
| MAT | 14 638 783 | -32.9% | 23.2% | -6.6 | 2 263 247 146 | -26.9% | 16.4% | -5.8 | -13.8% |
| MIG 400 | |||||||||
| WoW | 111 714 | 10.8% | 2.3% | 0 | 12 690 829 | 10.7% | 1.6% | 0 | 8.5% |
| MoM | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| YTD | 945 860 | -48.3% | 2.2% | -1.1 | 116 157 997 | -45.2% | 1.7% | -1 | -23.9% |
| MAT | 7 511 334 | -27.8% | 3.0% | -0.8 | 898 463 842 | -23.8% | 2.3% | -0.8 | -9.2% |
| PROSTAMOL | |||||||||
| WoW | 21 824 | 13.1% | 12.6% | -0.4 | 32 971 208 | 13.2% | 14.3% | -0.5 | 16.4% |
| MoM | 80 544 | -12.7% | 12.8% | -1 | 122 384 313 | -11.5% | 14.6% | -1 | -6.1% |
| YTD | 185 298 | -55.4% | 13.3% | -9.6 | 279 814 570 | -49.8% | 15.1% | -9.2 | -23.2% |
| MAT | 1 316 056 | -38.3% | 16.2% | -8 | 1 887 082 767 | -31.1% | 17.5% | -8.6 | -8.1% |
| RESPERO MYRTOL | |||||||||
| WoW | 24 342 | 7.5% | 6.9% | 0 | 13 950 764 | 6.1% | 8.2% | -0.1 | 7.5% |
| MoM | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
| YTD | 210 638 | -43.2% | 7.1% | -3.2 | 121 017 220 | -26.9% | 8.4% | -1.7 | -17.5% |
| MAT | 1 141 058 | 6.3% | 7.6% | 0.7 | 578 926 041 | 18.5% | 8.1% | 1 | -3.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 985 672 | -68.9% | 2.8% | -3.2 | 266 560 080 | -56.2% | 3.4% | -2.3 | -32.9% |
| DEXALGIN | 154 601 | -63.9% | 0.4% | -0.4 | 83 240 709 | -50.7% | 1.3% | -0.9 | -23.9% |
| ESPUMISAN (ADULTS) | 461 281 | -57.8% | 38.9% | -22.1 | 295 891 565 | -43.9% | 49.2% | -18 | -33.9% |
| ESPUMISAN BABY | 182 461 | -42.4% | 29.4% | -10 | 142 490 933 | -23.6% | 46.5% | -7.3 | -22.7% |
| FASTUM | 129 783 | -49.9% | 0.9% | -0.6 | 79 272 251 | -35.5% | 2.4% | -0.6 | -18.0% |
| IODOMARIN | 565 930 | -20.2% | 21.7% | -0.1 | 105 547 038 | -21.2% | 8.6% | -1 | -19.9% |
| LIOTON | 133 983 | -52.2% | 1.7% | -0.9 | 167 570 057 | -34.6% | 4.3% | -0.9 | -25.6% |
| MEZYM | 1 912 562 | -58.6% | 19.4% | -11.3 | 299 644 551 | -56.0% | 13.2% | -9.3 | -34.5% |
| MIG 400 | 945 860 | -48.3% | 2.2% | -1.1 | 116 157 997 | -45.2% | 1.7% | -1 | -23.9% |
| PROSTAMOL | 185 298 | -55.4% | 13.3% | -9.6 | 279 814 570 | -49.8% | 15.1% | -9.2 | -23.2% |
| RESPERO MYRTOL | 210 638 | -43.2% | 7.1% | -3.2 | 121 017 220 | -26.9% | 8.4% | -1.7 | -17.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 667 030 | -48.3% | 4.1% | -2.5 | 1 678 699 970 | -36.1% | 4.1% | -1.9 | -16.8% |
| DEXALGIN | 1 311 834 | -32.9% | 0.5% | -0.2 | 601 185 052 | -20.1% | 1.5% | -0.4 | -9.2% |
| ESPUMISAN (ADULTS) | 3 651 355 | -32.6% | 48.9% | -15.4 | 1 977 081 579 | -22.0% | 55.4% | -14.1 | -11.4% |
| ESPUMISAN BABY | 1 291 915 | -21.9% | 35.1% | -5.7 | 861 508 850 | -11.3% | 49.0% | -6.4 | -9.2% |
| FASTUM | 911 441 | -33.6% | 1.0% | -0.4 | 502 644 246 | -21.5% | 2.4% | -0.7 | -4.5% |
| IODOMARIN | 3 150 356 | -6.7% | 20.5% | -0.8 | 611 681 337 | -3.3% | 8.9% | -0.7 | -3.2% |
| LIOTON | 1 105 526 | -35.8% | 2.1% | -0.7 | 1 218 796 764 | -16.6% | 4.5% | -1.2 | -12.7% |
| MEZYM | 14 638 783 | -32.9% | 23.2% | -6.6 | 2 263 247 146 | -26.9% | 16.4% | -5.8 | -13.8% |
| MIG 400 | 7 511 334 | -27.8% | 3.0% | -0.8 | 898 463 842 | -23.8% | 2.3% | -0.8 | -9.2% |
| PROSTAMOL | 1 316 056 | -38.3% | 16.2% | -8 | 1 887 082 767 | -31.1% | 17.5% | -8.6 | -8.1% |
| RESPERO MYRTOL | 1 141 058 | 6.3% | 7.6% | 0.7 | 578 926 041 | 18.5% | 8.1% | 1 | -3.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 104 662 | 3.4% | 2.7% | 0 | 27 620 480 | 1.5% | 3.2% | -0.1 | 4.1% |
| DEXALGIN | 16 012 | 11.3% | 0.3% | 0 | 8 687 074 | 9.2% | 1.1% | 0 | 8.5% |
| ESPUMISAN (ADULTS) | 54 841 | 14.5% | 38.7% | 0 | 34 762 625 | 15.3% | 48.3% | 0 | 14.4% |
| ESPUMISAN BABY | 21 290 | 9.8% | 28.4% | -0.6 | 16 483 022 | 9.0% | 44.9% | -1.1 | 12.2% |
| FASTUM | 14 570 | 15.1% | 0.8% | 0 | 8 781 314 | 14.2% | 2.1% | -0.1 | 16.6% |
| IODOMARIN | 74 336 | 21.7% | 22.5% | 0.3 | 13 975 308 | 21.5% | 9.3% | 0.4 | 20.2% |
| LIOTON | 15 328 | 6.0% | 1.5% | -0.2 | 19 622 736 | 9.9% | 4.0% | -0.4 | 18.2% |
| MEZYM | 211 238 | 4.4% | 19.0% | -0.9 | 33 536 102 | 5.7% | 12.8% | -0.3 | 9.5% |
| MIG 400 | 111 714 | 10.8% | 2.3% | 0 | 12 690 829 | 10.7% | 1.6% | 0 | 8.5% |
| PROSTAMOL | 21 824 | 13.1% | 12.6% | -0.4 | 32 971 208 | 13.2% | 14.3% | -0.5 | 16.4% |
| RESPERO MYRTOL | 24 342 | 7.5% | 6.9% | 0 | 13 950 764 | 6.1% | 8.2% | -0.1 | 7.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| DEXALGIN | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| ESPUMISAN (ADULTS) | 202 093 | -11.2% | 38.4% | -1 | 128 123 690 | -13.1% | 48.0% | -2.2 | -8.9% |
| ESPUMISAN BABY | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| FASTUM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| IODOMARIN | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| LIOTON | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.7% |
| MEZYM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| MIG 400 | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| PROSTAMOL | 80 544 | -12.7% | 12.8% | -1 | 122 384 313 | -11.5% | 14.6% | -1 | -6.1% |
| RESPERO MYRTOL | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs